Sandbox ID Gastrointestinal and Intraabdominal: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
:* Shigella species: | :* Shigella species: | ||
::*Preferred regimen: | ::*Preferred regimen: | ||
:::*Adult dose: [[TMP-SMZ]], 160 and 800 mg, respectively b.i.d. x 3 d (if susceptible ) {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], {{or}} 500 mg [[ciprofloxacin]] b.i.d. | :::*Adult dose: [[TMP-SMZ]], 160 and 800 mg, respectively b.i.d. x 3 d (if susceptible ) {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], {{or}} 500 mg [[ciprofloxacin]] b.i.d. for 3 days) | ||
:::*Pediatric dose:TMP-SMZ, 5 and 25 mg/kg, respectively b.i.d. | :::*Pediatric dose:TMP-SMZ, 5 and 25 mg/kg, respectively b.i.d. for 3 days | ||
::*Preferred regimen: | ::*Preferred regimen: | ||
| Line 30: | Line 30: | ||
::*Enterotoxigenic | ::*Enterotoxigenic | ||
:::*Preferred regimen: | :::*Preferred regimen: | ||
::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d.,X 3 d (if susceptible), {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. | ::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d.,X 3 d (if susceptible), {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. for 3 days) | ||
::*Enteropathogenic | |||
:::*Preferred regimen: | |||
::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d.,X 3 d (if susceptible), {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. for 3 days) | |||
---- | ---- | ||
Revision as of 14:26, 29 May 2015
Gastrointestinal anthrax
- Gastrointestinal anthrax
- Preferred regimen: Ciprofloxacin 400 mg intravenously every 8 h OR doxycycline 100 mg intravenously every 12 h combined with second agent: clindamycin 600 mg intravenously every 8 h or penicillin G 4 MU every 4–6 h OR meropenem 1 gm intravenously every 6–8 h or rifampin 300 mg every 12 h.
Infectious diarrhea
- Infectious diarrhea
Immunocompetent
- Shigella species:
- Preferred regimen:
- Adult dose: TMP-SMZ, 160 and 800 mg, respectively b.i.d. x 3 d (if susceptible ) OR fluoroquinolone (e.g., 300 mg ofloxacin, 400 mg norfloxacin, OR 500 mg ciprofloxacin b.i.d. for 3 days)
- Pediatric dose:TMP-SMZ, 5 and 25 mg/kg, respectively b.i.d. for 3 days
- Preferred regimen:
- Adult dose: Nalidixic acid 1 g/d X 5 d OR ceftriaxone; azithromycin
- Pediatric dose: Nalidixic acid, 55 mg/kg/d
- Campylobacter species
- Preferred regimen:
- Erythromycin, 500 mg b.i.d. X 5 d
- Escherichia coli species
- Enterotoxigenic
- Preferred regimen:
- TMP-SMZ, 160 and 800 mg, respectively, b.i.d.,X 3 d (if susceptible), OR fluoroquinolone (e.g., 300 mg ofloxacin, 400 mg norfloxacin, or 500 mg ciprofloxacin b.i.d. for 3 days)
- Enteropathogenic
- Preferred regimen:
- TMP-SMZ, 160 and 800 mg, respectively, b.i.d.,X 3 d (if susceptible), OR fluoroquinolone (e.g., 300 mg ofloxacin, 400 mg norfloxacin, or 500 mg ciprofloxacin b.i.d. for 3 days)
Peptic ulcer disease
- Peptic ulcer disease
Esophagitis
- Esophagitis